Who is sponsoring NCT00719056?

NCT00719056 is sponsored by University of Athens.

What condition does NCT00719056 study?

NCT00719056 studies Total Hip and Knee Arthroplasties.

What drugs are being tested in NCT00719056?

Interventions: Teicoplanin, β-lactams or ciprofloxacin.

What is the status of NCT00719056?

NCT00719056 is currently COMPLETED.

Last reviewed 2008-07-18 · How we verify

Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study

NCT00719056 Phase 4 COMPLETED

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with teicoplanin or with other antibiotics. The study is aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

Details

Lead sponsor	University of Athens
Phase	Phase 4
Status	COMPLETED
Enrolment	616
Start date	2004-08
Completion	2007-12

Conditions

Total Hip and Knee Arthroplasties

Interventions

Teicoplanin
β-lactams or ciprofloxacin

Primary outcomes

To compare the efficacy of single dose teicoplanin compared with comparator agents in the prevention of surgical site infections after total hip or knee arthroplasty. — Two years

Countries

Greece